We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-3.69%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.23B
AUM Growth
+$247M
Cap. Flow
+$266M
Cap. Flow %
21.66%
Top 10 Hldgs %
61.87%
Holding
776
New
234
Increased
119
Reduced
104
Closed
282

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$172M
2
FCX icon
Freeport-McMoran
FCX
+$166M
3
TSLA icon
Tesla
TSLA
+$92.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$27.5M
5
PFE icon
Pfizer
PFE
+$25.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.5%
2 Healthcare 17.22%
3 Materials 15.97%
4 Technology 5.36%
5 Financials 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIA
476
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$94K 0.01%
2,281
-1,927
-46% -$102K
TCRT icon
477
Alaunos Therapeutics
TCRT
$4.81M
$92K 0.01%
942
UUUU icon
478
Energy Fuels
UUUU
$3.69B
$92K 0.01%
+10,000
New +$78K
ZNGA
479
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$92K 0.01%
+10,000
New +$87.8K
IMMR icon
480
Immersion
IMMR
$248M
$91K 0.01%
16,302
XBIT icon
481
XBiotech
XBIT
$71M
$89K 0.01%
10,309
SAND
482
DELISTED
Sandstorm Gold
SAND
$81K 0.01%
+10,000
New +$69K
GOTU icon
483
Gaotu Techedu
GOTU
$429M
$75K 0.01%
43,657
-10,266
-19% -$19.5K
NCMI icon
484
National CineMedia
NCMI
$355M
$74K 0.01%
+2,906
New +$80.9K
CTIC
485
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$67K 0.01%
+14,405
New +$43K
OVID icon
486
Ovid Therapeutics
OVID
$482M
$55K ﹤0.01%
17,386
NPKI
487
NPK International
NPKI
$1.18B
$53K ﹤0.01%
14,446
-54,286
-79% -$202K
XLF icon
488
State Street Financial Select Sector SPDR ETF
XLF
$59B
$48K ﹤0.01%
1,250
-126,301
-99% -$4.94M
ZEPP
489
Zepp Health
ZEPP
$75.5M
$48K ﹤0.01%
+4,200
New +$67.8K
KSA icon
490
iShares MSCI Saudi Arabia ETF
KSA
$623M
$47K ﹤0.01%
+1,000
New +$45.5K
AMJ
491
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$42K ﹤0.01%
+2,000
New +$40.2K
CMCM
492
Cheetah Mobile
CMCM
$98.1M
$39K ﹤0.01%
8,011
RBBN icon
493
Ribbon Communications
RBBN
$356M
$37K ﹤0.01%
+11,895
New +$48.7K
XLU icon
494
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
$7K ﹤0.01%
200
ABM icon
495
ABM Industries
ABM
$2.83B
-6,701
Closed -$274K
ACA icon
496
Arcosa
ACA
$7.12B
-9,095
Closed -$479K
AEHR icon
497
Aehr Test Systems
AEHR
$3.82B
-24,681
Closed -$597K
AGCO icon
498
AGCO
AGCO
$7.1B
-3,149
Closed -$365K
AIV
499
Aimco
AIV
$376M
-56,038
Closed -$433K
AIZ icon
500
Assurant
AIZ
$13.9B
-5,822
Closed -$907K

Similar funds

Caxton Associates (New York)'s Q1 2022 Portfolio in Review

As of Q1 2022, Caxton Associates (New York) held 776 positions worth $1.23B, up 25% from $982M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Caxton Associates (New York) deployed $266M of net new capital in Q1 2022, opening 234 new positions and adding to 119 existing holdings. Its largest new stake was Aptiv: 1,293,400 shares worth $155M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Amazon, an estimated $7.44M trimmed.

  • Caxton Associates (New York)'s largest Q1 2022 buy was Aptiv: 1,293,400 shares worth $155M.
  • Caxton Associates (New York) added most to Tesla in Q1 2022, an estimated $92.7M increase.
  • Caxton Associates (New York)'s biggest Q1 2022 reduction was Amazon, cutting an estimated $7.44M.
  • Caxton Associates (New York) fully exited State Street SPDR S&P 500 ETF Trust in Q1 2022, selling an estimated $79M.
  • Caxton Associates (New York)'s ten largest holdings make up 62% of its $1.23B portfolio in Q1 2022.
  • Caxton Associates (New York) opened 234 new positions and closed 282 in Q1 2022.
  • Caxton Associates (New York)'s portfolio value rose 25% quarter-over-quarter to $1.23B.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.